ArticleClinical, cosmetic and investigational dermatology2026
Robustness Analyses Substantially Narrow in silico Network-Toxicology Signals Linking Selected Pharmaceuticals and Caffeine to Vitiligo.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Network-toxicology and molecular-docking pipelines are widely used to link environmental chemicals to disease targets, but their outputs are rarely subjected to external validation, background-aware significance testing, or promiscuity controls. Methods: This fully computational (in silico) study applied a conventional network-toxicology and molecular-docking pipeline to vitiligo and eleven compounds-caffeine, four antibiotics, two angiotensin-receptor blockers, two statins, a proton-pump inhibitor and an antidepressant-adopted verbatim from a published study, holding chemical input constant. The output was stress-tested by core-tier threshold sensitivity, external cross-platform validation in two independent cohorts with the receiver-operating-characteristic (ROC) direction fixed in advance, background-restricted overlap-significance testing, and caffeine-exclusion sensitivity analysis. Results: The 102-gene target set did not intersect the high-confidence vitiligo core tier (overlap = 0, stable above 0.170) and gave a 22-gene extended-tier intersection, in which HIF1A was the highest-degree node and five key differentially expressed genes discriminated lesional from non-lesional skin at areas under the ROC curve (AUC) of 0.73-0.87. Every check degraded this. The overlap was enriched against a protein-coding background (fold 2.49, p = 5.1×10 Conclusion: Validation and robustness checks converted an apparently supported mechanistic network into a result with no surviving gene-level candidate. The most consequential was a library default: within-cohort ROC direction selection turned a contradicted gene into the apparently strongest validation. Such checks should be standard, not optional. No causal or exposure-related association was demonstrated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.